Changchun BCHT Biotechnology Valuation

Q: What is the Fair Price of 688276 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

688276 (CN¥26.37) is trading above our estimate of [[fair value]] (CN¥6.34)

Is 688276 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688276 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688276 (CN¥26.37) is trading above our estimate of fair value (CN¥6.34)

Significantly Below Fair Value: 688276 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688276?

Key metric: As 688276 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688276. This is calculated by dividing 688276's market cap by their current earnings.
What is 688276's PE Ratio?
PE Ratio	26.3x
Earnings	CN¥414.29m
Market Cap	CN¥10.91b

688276 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.7x
Enterprise Value/EBITDA	19.2x
PEG Ratio	0.7x

Price to Earnings Ratio vs Peers

How does 688276's PE Ratio compare to its peers?

The above table shows the PE ratio for 688276 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	27.1x
300685 Amoy Diagnostics	31.5x	19.6%	CN¥9.9b
688336 Sunshine Guojian Pharmaceutical (Shanghai)	38.8x	-11.7%	CN¥14.1b
300009 Anhui Anke Biotechnology (Group)	19.1x	16.7%	CN¥15.0b
000403 Pacific Shuanglin Bio-pharmacy	19.1x	12.7%	CN¥15.8b
688276 Changchun BCHT Biotechnology	26.3x	39.3%	CN¥10.9b

Price-To-Earnings vs Peers: 688276 is good value based on its Price-To-Earnings Ratio (26.3x) compared to the peer average (27.1x).

Price to Earnings Ratio vs Industry

How does 688276's PE Ratio compare vs other companies in the CN Biotechs Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 688276 is good value based on its Price-To-Earnings Ratio (26.3x) compared to the CN Biotechs industry average (35.6x).

Price to Earnings Ratio vs Fair Ratio

What is 688276's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688276 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	26.3x
Fair PE Ratio	36.1x

Price-To-Earnings vs Fair Ratio: 688276 is good value based on its Price-To-Earnings Ratio (26.3x) compared to the estimated Fair Price-To-Earnings Ratio (36.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688276 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥26.37	CN¥31.99 +21.3%	0.05%	CN¥32.00	CN¥31.97	n/a	2
Nov ’25	CN¥25.45	CN¥39.37 +54.7%	26.5%	CN¥54.13	CN¥31.97	n/a	3
Oct ’25	CN¥30.60	CN¥39.37 +28.6%	26.5%	CN¥54.13	CN¥31.97	n/a	3
Sep ’25	CN¥24.35	CN¥39.37 +61.7%	26.5%	CN¥54.13	CN¥31.97	n/a	3
Aug ’25	CN¥29.89	CN¥54.57 +82.6%	0.8%	CN¥55.00	CN¥54.13	n/a	2
Jul ’25	CN¥31.09	CN¥54.57 +75.5%	0.8%	CN¥55.00	CN¥54.13	n/a	2
Jun ’25	CN¥34.00	CN¥54.57 +60.5%	0.8%	CN¥55.00	CN¥54.13	n/a	2
May ’25	CN¥39.07	CN¥54.57 +39.7%	0.8%	CN¥55.00	CN¥54.13	n/a	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Sichuan Kelun Pharmaceutical

CN¥51.9b

Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.

2422

CN¥32.72

7.3%

15.1%

China Resources Sanjiu Medical & Pharmaceutical

CN¥57.9b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

999

CN¥45.11

-1.3%

19.5%